Gamma scintigraphy is an advanced imaging technique used to track and visualize drug delivery inside the human body. By using safe, trace amounts of radiolabels, it provides real-time images that show exactly how a drug or medical device performs in vivo. This non-invasive technique is widely used in pharmaceutical development to assess inhaled, oral, nasal, and other targeted drug delivery systems. Gamma scintigraphy helps pharmaceutical companies, medical device developers, and clinicians understand how formulations behave in the body — data that cannot be obtained through in vitro testing alone.
Visualise how drugs disperse, deposit, and clear from target organs like the lungs, GI tract, or nasal cavity.
Measure exactly how much of the dose reaches the intended site.
Verify that inhalers, nebulisers, nasal sprays, or oral delivery systems are performing as designed.
Provide robust, visual evidence to strengthen regulatory submissions for new drug products or devices.
Identify formulation or device issues early to avoid delays and reduce development risks.
For Pharmaceutical Formulators: Gain crucial insights into how your formulation behaves in the human body. Understand drug release, absorption, and clearance to optimise performance. For Drug Delivery Device Manufacturers: Confirm that your inhalers, sprays, or oral devices deliver drugs accurately and reproducibly to the target site. For Clinicians and Researchers: Use real-time drug delivery data to improve treatment strategies, dosing, and patient outcomes.What is Gamma Scintigraphy
What Gamma Scintigraphy Offers
In Vivo Drug Delivery Imaging
Quantitative Drug Deposition Data
Device and Formulation Validation
Regulatory Support
Faster, Smarter Development
Overview of Gamma Scintigraphy for Product Development
